EUVIMEDOpdag EUVIMED
EUVIMED · CrossrefJournal

Leukemia Research

ISSN 0145-2126 · Elsevier BV

Latest articles

  1. Avapritinib versus midostaurin or cladribine in advanced systemic mastocytosis: A retrospective real-world external control study

    Andreas Reiter, Jason Gotlib, Iván Álvarez-Twose, Deepti H. Radia, Johannes Lübke, Priyanka J. Bobbili, Aolin Wang, Saša Dimitrijević, Erin Sullivan, Juliana Schwaab, Ilene A. Galinsky, Cecelia Perkins, Wolfgang R. Sperr, Priya Sriskandarajah, Manasi Mohan, Teshawna Badu, Selvam R. Sendhil, Mei Sheng Duh, Peter Valent, Daniel J. DeAngelo

    Published: 2025-10DOI: 10.1016/j.leukres.2025.107919

  2. Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter study

    Francesca Palandri, Massimo Breccia, Erika Morsia, Elena M. Elli, Giulia Benevolo, Mario Tiribelli, Eloise Beggiato, Mirko Farina, Giovanni Caocci, Novella Pugliese, Alessia Tieghi, Monica Crugnola, Gianni Binotto, Francesco Cavazzini, Alessandro Isidori, Alessandra Dedola, Emilia Scalzulli, Alessia Moioli, Fabrizio Cavalca, Santino Caserta, Andrea Duminuco, Bruno Martino, Roberto M. Lemoli, Daniela Cilloni, Monica Bocchia, Fabrizio Pane, Florian H. Heidel, Massimiliano Bonifacio, Giuseppe A. Palumbo, Filippo Branzanti, Alessandra Iurlo, Elisabetta Abruzzese

    Published: 2025-07DOI: 10.1016/j.leukres.2025.107719

  3. A phase I study of the myeloid cell leukemia 1 (MCL1) inhibitor tapotoclax (AMG 176) in patients with myelodysplastic syndromes after hypomethylating agent failure

    Kelly S. Chien, Juan Jose Rodriguez-Sevilla, Yesid Alvarado, Guillermo Montalban-Bravo, Danielle E. Hammond, Mahesh Swaminathan, Alexandre Bazinet, Jacqueline Kimberley, Kristy Bodden, Heather Schneider, Xiao Qin Dong, Sherry A. Pierce, Xuelin Huang, Elias J. Jabbour, Hagop M. Kantarjian, Guillermo Garcia-Manero

    Published: 2024-12DOI: 10.1016/j.leukres.2024.107602

Volumes

2026 · 1022025 · 3912024 · 1162023 · 3452022 · 2682021 · 2942020 · 1332019 · 3942018 · 2302017 · 5062016 · 2322015 · 5572014 · 4312013 · 6902012 · 3772011 · 8102010 · 4442009 · 6712008 · 3532007 · 7712006 · 3282005 · 4262004 · 2432003 · 1842002 · 1842001 · 1662000 · 1451999 · 1951998 · 1711997 · 3731996 · 1441995 · 1481994 · 2551993 · 1681992 · 1851991 · 3101990 · 1591989 · 1601988 · 1481987 · 172

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.